DelveInsight's Hereditary Transthyretin Amyloidosis Market Insights report includes a comprehensive understanding of current ...

A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...

Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present a NXC-201 abstract at the upcoming ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

People with Sweet's syndrome often wake up with a fever, body aches, and blisters on their neck, limbs and face. Also known ...

Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of ...

As the industry loses one of its key female leaders in GSK CEO Emma Walmsley, BioSpace profiles the women leading the ...

Heart failure now accounts for 45% of cardiovascular deaths and approximately one-quarter of Americans will have it in their ...

An updated report on statistics regarding heart failure epidemiology and outcomes has been published by the HFSA.

AstraZeneca has snapped up another Ionis-discovered drug for its pipeline, this time phase 3 candidate eplontersen for the disease transthyretin amyloidosis (ATTR). The deal is another sizeable one ...

The Broncos turned into a GM factory under Elway, as four current and two former GMs were in Denver under his Super ...

After experiencing discrimination while growing up in Nova Scotia, he became a strong voice against anti-Black racism and was ...